3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
16
Phase EARLY_PHASE1
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
256
Breast Neoplasms
172
Neoplasms
166
Colorectal Neoplasms
155
Neoplasm Metastasis
126
Melanoma
118
Recurrence
117
Prostatic Neoplasms
116
Leukemia, Myeloid, Acute
115
Pancreatic Neoplasms
113
Ovarian Neoplasms
109
Multiple Myeloma
104
Lung Neoplasms
95
Stomach Neoplasms
89
Squamous Cell Carcinoma of Head and Neck
82
Triple Negative Breast Neoplasms
81
Glioblastoma
81
Lymphoma
76
Lymphoma, Non-Hodgkin
75
Carcinoma, Renal Cell
65
Lymphoma, Large B-Cell, Diffuse
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
62
Advanced Solid Tumor
59
Endometrial Neoplasms
58
Carcinoma, Hepatocellular
58
Small Cell Lung Carcinoma
54
Uterine Cervical Neoplasms
52
Sarcoma
52
Myelodysplastic Syndromes
51
Advanced Solid Tumors
49
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Insulin Resistance
×
1 year
×
Clear all
NCT05455619
2026-04-22
Amelia-1
SynDevRx, Inc.
Phase 1/2
Recruiting
52 enrolled